New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2013
13:55 EDTDRI, DRI, DRIDarden to host an investor and analyst meeting
Investor and Analyst Meeting is being held in Orlando on February 25-26 with webcast on February 25 starting at 2 pm. Webcast Link
News For DRI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent DRI news | >>
March 23, 2015
08:55 EDTDRIDarden upgraded at Telsey Advisory
Subscribe for More Information
06:17 EDTDRIDarden upgraded to Outperform from Market Perform at Telsey Advisory
Subscribe for More Information
March 20, 2015
12:41 EDTDRIOn The Fly: Midday Wrap
Stocks began the day sharply higher and have continued to tack on gains throughout the morning. The marketís move put the Nasdaq back above 5,000 and the S&P above 2,100. The market is undergoing quadruple witching, which occurs 4 times per year and typically is accompanied by high volume and volatility. ECONOMIC EVENTS: In the U.S., the economic calendar was quiet. The Baker Hughes U.S. rig count, which has been closely watched in recent months amid the protracted slide in oil prices, is expected at 1:00 pm EDT. The count of U.S. rigs stood at 1125 at the end of last week. In Europe, reports indicate German Chancellor Angela Merkel said Greece has agreed to send a list of overhauled reforms to European officials within days. COMPANY NEWS: Shares of Nike (NKE) advanced 4% following its Q3 earnings beat. Credit Suisse raised Nike's price target to $106 following the report, saying Nike's underlying futures growth remains in double-digits and preliminary FY16 guidance suggests management has been effective in managing currency headwinds... The shares of Biogen (BIIB) rallied 8% after the company reported results for an early stage study of its Alzheimer's drug, BIIB-037. The company announced that the three milligram, six milligram, and ten milligram dose versions of its Alzheimer's treatment, aducanumab, had reduced the amount of amyloid plaque in the brains of Alzheimer's patients taking the drug by statistically significant amounts compared with those taking placebos. The cognitive decline of patients taking BIIB-037 was also significantly less than that of patients who were taking placebos, the company reported. MAJOR MOVERS: Among the notable gainers was Prothena (PRTA), which surged 30% after announcing results from a Phase 1 single ascending dose study of its potential treatment of Parkinson's disease. Also higher was Darden Restaurants (DRI), which gained 4% after the owner of the Olive Garden and Long Horn restaurant chains reported earnings that beat expectations. Among the noteworthy losers was China's Youku Tudou (YOKU), which dropped 9% and was downgraded to Sell at Deutsche Bank after the company reported mixed Q4 results. Also lower was Theravance (THRX), which fell 7% after the company and partner GlaxoSmithKline (GSK) announced that an FDA advisory committee voted that the efficacy data for their Breo Ellipta inhaler provides substantial evidence of a clinically meaningful benefit in adults, however it voted against approval for the proposed indication in 12-17 year olds. INDEXES: Near midday, the Dow was up 189.04, or 1.05%, to 18,148.07, the Nasdaq was up 40.24, or 0.81%, to 5,032.62, and the S&P 500 was up 19.54, or 0.94%, to 2,108.81.
09:24 EDTDRIOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Ctrip.com (CTRP), up 20.1%... Rally Software (RALY), up 17.3%... Nike (NKE), up 5.2%... Darden Restaurants (DRI), up 4.3%... Cheetah Mobile (CMCM), up 3.6%. ALSO HIGHER: Prothena (PRTA), up 40.2% after reporting positive results from Phase 1 study of PRX002... Viggle (VGGL), up 26.9% after confirming receipt of offer from chairman and CEO Robert Sillerman... Intercept Pharmaceuticals (ICPT), up 8.5% after announcing new data analyses from FLINT trial... Biogen Idec (BIIB), up 9.7% after presenting positive interim results from study of aducanumab... Pier 1 Imports (PIR), up 5.2% after being upgraded to Outperform from Perform at Oppenheimer... JinkoSolar (JKS), up 2.8% after announcing that it will supply 75 MWdc of its PV solar modules to Red Horse 2 project and following a strategic collaboration agreement with DuPont (DD). DuPont is up just under 1%. DOWN AFTER EARNINGS: AK Steel (AKS), down 6.8%... Youku Tudou (YOKU), down 4.9%... Tiffany (TIF), down 3.3%. ALSO LOWER: Macerich (MAC), down 7.7% after Simon makes $95.50 per share "best and final" offer.
09:07 EDTDRIDarden says $90M-$100M cost saving target a 'starting' point
Subscribe for More Information
08:52 EDTDRIDarden says had identified potential for $90M-$100M in annualized cost savings
Sees realizing $30M of target saving in this fiscal year recognizing $40M-$50M more in FY16 and sees recognizing full target of annualized savings by FY17. Comments made on Q3 earnings conference call.
08:51 EDTDRIDarden says search for new CFO 'well underway'
Subscribe for More Information
08:49 EDTDRIDarden sees issuing FY16 outlook in June with earnings call
08:45 EDTDRIDarden says has listed 31 properties for triple-net sale leaseback
Subscribe for More Information
08:40 EDTDRIDarden price target raised to $70 from $62 at KeyBanc
Subscribe for More Information
07:04 EDTDRIDarden reports Q3 Olive Garden sales up 3% to $957M
Subscribe for More Information
07:04 EDTDRIDarden sees FY15 adjusted EPS $2.45-$2.48, consensus $2.30
Subscribe for More Information
07:03 EDTDRIDarden sees Q4 adjusted EPS 91c-94c, consensus 89c
07:02 EDTDRIDarden reports Q3 comparable same-restaurant sales up 3.6%
Subscribe for More Information
07:01 EDTDRIDarden reports Q3 adjusted EPS 99c, consensus 84c
Subscribe for More Information
March 19, 2015
15:19 EDTDRINotable companies reporting before tomorrow's open
Subscribe for More Information
14:31 EDTDRIDarden March 62 straddle priced for 3.3% movement into Q3
March 18, 2015
08:47 EDTDRIDarden March volatility elevated into Q3 and outlook
Darden March call option implied volatility is at 64, April is at 28, July is at 22; compared to its 26-week average of 24 according to Track Data, suggesting large near term price movement into the expected release of Q3 results on March 20.
March 13, 2015
08:27 EDTDRIDarden March volatility elevated into Q3 and outlook
Subscribe for More Information
07:40 EDTDRIDarden earnings catalysts not reflected in estimates, says Oppenheimer
Subscribe for More Information
1 | 2 | all recent DRI news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use